Connect with us
[the_ad id="89560"]

Autism

RFK Jr. and HHS: Autism is linked to MMR vaccine, Tylenol use during pregnancy

Published

4 minute read

From LifeSiteNews

By Emily Mangiaracina

During a Senate hearing yesterday, Kennedy noted that a CDC study found a 260% higher rate of autism in boys who got the MMR vaccine.

A Department of Health and Human Services (HHS) report commissioned by Robert F. Kennedy Jr. indicates Tylenol use during pregnancy is one factor contributing to the U.S. autism epidemic, according to media reports.

Sources close to the matter said low levels of folate as well as the use of the acetaminophen-based drug will be named in the forthcoming HHS autism report as among potential causal factors behind autism.

Kennedy, secretary of the HHS, told Fox and Friends last week that his agency was about to reveal causes of autism and make government regulation recommendations accordingly. His remarks suggest that mothers’ Tylenol use and folate deficiency will be among a multitude of factors cited in the HHS report.

“There is not a single cause, there are many, many — there’s an aggregation of causes,” said Kennedy. “We are now developing sufficient evidence to ask for regulatory action on some of those, or recommendations.”

He noted the documented explosion in autism rates, which have gone from less than one in 10,000 in 1970 to one case for every 31 Americans, according to the Centers for Disease Control and Prevention (CDC). Even if autism is over-diagnosed, a significant portion of these children are severely impaired, indicating a real, notable increase in the disorder.

“Most cases now are severe,” Kennedy said in April while discussing the results of a CDC autism survey. He explained that “25% of the kids who are diagnosed with autism are non-verbal, non-toilet trained,” and have other dysfunctional behaviors typical of severe autism like head-banging.

During a Senate hearing on Thursday, Kennedy also pointed to a link between the Measles, Mumps, and Rubella (MMR) vaccine and autism.

“In 2002, CDC did an internal study of Fulton County, Georgia, children, and looked at children who got the MMR vaccine on time and compared those to kids who got them later. The data from that study showed that black boys who got the vaccine on time had a 260% greater chance of getting an autism diagnosis than children who waited,” Kennedy explained.

“The chief scientist on that, Dr. William Thompson, the senior vaccine safety scientist at CDC, was ordered to come into a room with four other co-authors by his boss, Frank DeStefano, who’s the head of the Immunization Safety Branch, in order to destroy that data,” said Kennedy.

While an evolving, broadening definition of autism may contribute to increased diagnoses, Kennedy believes “environmental toxins” have contributed to a full-blown epidemic of autism.

“We’re going to look at vaccines, but we’re going to look at everything. Everything is on the table, our food system, our water, our air, different ways of parenting, all the kind of changes that may have triggered this epidemic,” the HHS head previously told Fox News.

“It is an epidemic,” Kennedy insisted. “Epidemics are not caused by genes. Genes can provide a vulnerability, but you need an environmental toxin.”

“We know that it is an environmental toxin that is causing this cataclysm,” said Kennedy, “and we are going to identify it.”

Autism

NIH, CMS partner on autism research

Published on

From The Center Square

By 

Officials at the the National Institutes of Health and the Centers for Medicare & Medicaid Services announced a partnership Wednesday to research “root causes of autism spectrum disorder.”

As part of the project, NIH will build a real-world data platform enabling advanced research across claims data, electronic medical records and consumer wearables, according to the agencies.

“We’re using this partnership to uncover the root causes of autism and other chronic diseases,” said HHS Secretary Robert F. Kennedy Jr. “We’re pulling back the curtain – with full transparency and accountability – to deliver the honest answers families have waited far too long to hear.”

CMS and NIH will start this partnership by establishing a data use agreement under CMS’ Research Data Disclosure Program focused on Medicare and Medicaid enrollees with a diagnosis of autism spectrum disorder or ASD.

“This partnership is an important step in our commitment to unlocking the power of real-world data to inform public health decisions and improve lives,” NIH Director Dr. Jay Bhattacharya said. “Linking CMS claims data with a secure real-world NIH data platform, fully compliant with privacy and security laws, will unlock landmark research into the complex factors that drive autism and chronic disease – ultimately delivering superior health outcomes to the Americans we serve.”

Researchers will focus on autism diagnosis trends over time, health outcomes from specific medical and behavioral interventions, access to care and disparities by demographics and geography and the economic burden on families and healthcare systems, according to a news release.

Continue Reading

Autism

UK plans to test children with gender confusion for autism

Published on

From LifeSiteNews

By Jonathon Van Maren

All children referred to a ‘gender clinic’ in the UK will soon be screened for autism and other ‘neurodevelopmental conditions’ due to the high rate of autism among gender-confused people.

According to The Telegraph, the National Health Service has drafted plans to test all children who believe they are “transgender” for autism due to findings in the Cass Review, which noted that “mental health conditions were disproportionately common among children and young people with gender dysphoria.” 

“Every child referred to a gender clinic will be ‘screened for neurodevelopmental conditions’ such as autism and ADHD under new guidance,” The Telegraph reported. “Medics will also evaluate each child’s mental health, their relationship with their family and their sexual development, including whether they are experiencing same-sex attraction.”  

Many parents, experts, and psychiatrists have been calling for such screenings for years, but transgender activists pushing the so-called “gender-affirming care” model refused to consider the intersection of autism and other factors and gender dysphoria. Consequently, many parents have seen their autistic children sucked into the gender ideology; the newsletter Parents with Inconvenient Truths about Trans has published heartbreaking stories almost weekly.  

The NHS will now be moving away from the “medical model” or “gender-affirming care” to a “holistic” approach. This new guidance will be released for public consultation shortly and come into effect later in 2025. According to The Telegraph: 

However, some groups criticized a “serious flaw” in the policy as it leaves an open door to the use of cross-sex hormones. They also condemned its absence of recognition of the wider societal issues to which children are exposed. The new NHS Children and Young People’s Gender Service will explore eight key areas of a child’s life. 

To assess “development”, doctors will take a “detailed history” of the child’s social, cognitive and physical growth, particularly because of the “substantial” changes that take place during puberty. They will screen children for autism and learning disabilities and look into whether further “cognitive assessments” are necessary. 

The specification says: “Given the high prevalence of neurodiversity identified within this population, all those attending the NHS Children and Young People’s Gender Service should receive screening for neurodevelopmental conditions.” The “multidisciplinary team” of experts, including a consultant specializing in neurodevelopmental disorders, will create a treatment plan for each individual depending on their diagnosis. 

If, during the screening, a “neurodevelopmental condition” is identified, a referral to the Paediatric Neurodevelopmental Service or Paediatric ASD Service will be likely, according to the guidance. Physicians will seek to determine whether the child’s symptoms are a result of underlying conditions or gender dysphoria, and their conditions will be reviewed longer term. Dr. Michael Craig, the clinical lead from the NHS National Autism Unit from 2007 to 2023, “previously estimated half of patients seen by Tavistock’s clinic had autism after observing sessions.”  

Hilary Cass observed the same trend, noting that one study found that autism was a “common denominator” in people identifying as transgender, with a recent study determining that gender-confused people were three to six times more likely to be autistic. The spike in girls identifying as transgender, Cass noted, was in part due to “undiagnosed autism, which is often missed in adolescent girls.” The new NHS guidance noted that there has been a “reluctance to explore or address” mental health issues, in part because gender dysphoria has not been classified as a mental illness under the “gender-affirming care” model. 

The new holistic NHS approach will also include examining the social context of children struggling with gender dysphoria: 

Another key area is dubbed “family context”, with medics being tasked to paint a picture of each child’s upbringing and familial relationships. The specification noted that “there is evidence of an increased frequency of family parental physical and/or mental ill health and other family stressors in this group”.

Under the section titled sexual development, knowledge and sexual orientation, it said “clinicians should seek to understand the child/young person’s emerging sexuality and sexual orientation”. If this has been a previous issue, doctors should consider whether the child was exposed to “adversity and trauma”. They will also examine the children’s physical health needs and the impact of any long-term conditions, along with their broader well-being, school relationships and educational attainment.

Critics of “gender-affirming care” have been enthusiastic about this proposed guidance, with Dr. Louise Irvine of the Clinical Advisory Network on Sex and Gender telling The Telegraph that: “The new service recognizes that many also experience mental health, neurodevelopmental and/or personal, family or social complexities in their lives. The challenge will be to ensure NHS services can provide prompt access to appropriate service for any identified needs as waiting lists are currently very long.” Irvine did note the “serious flaw” in the guidance being that it “leaves the door open for referral of children and young people under 18 for cross-sex hormones,” which she called unscientific and “irresponsible.” 

Featured Image

Jonathon Van Maren

Jonathon’s writings have been translated into more than six languages and in addition to LifeSiteNews, has been published in the National PostNational ReviewFirst Things, The Federalist, The American Conservative, The Stream, the Jewish Independent, the Hamilton SpectatorReformed Perspective Magazine, and LifeNews, among others. He is a contributing editor to The European Conservative.

His insights have been featured on CTV, Global News, and the CBC, as well as over twenty radio stations. He regularly speaks on a variety of social issues at universities, high schools, churches, and other functions in Canada, the United States, and Europe.

He is the author of The Culture WarSeeing is Believing: Why Our Culture Must Face the Victims of AbortionPatriots: The Untold Story of Ireland’s Pro-Life MovementPrairie Lion: The Life and Times of Ted Byfield, and co-author of A Guide to Discussing Assisted Suicide with Blaise Alleyne.

Jonathon serves as the communications director for the Canadian Centre for Bio-Ethical Reform.

Continue Reading

Trending

X